Keywords: synthelabo, french, launch, laboratoires, introduced, onto, market
SYNTHELABO FRENCH LAUNCH
Article | 26 April 1993
- Laboratoires Synthelabo has introduced onto the market in France a 200mg tablet formulation of its antipsychotic drug Solian (amisulpride). Amisulpride ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
